Using a technology called VirScan to study coronavirus antibody responses in a large cohort of SARS-CoV-2-infected and control individuals, researchers identified epitopes recognized by a large fraction of COVID-19 patients, epitopes cross-reactive with antibodies developed in response to other human coronaviruses, and 10 epitopes likely recognized by neutralizing antibodies. They used this VirScan data to design a tool for rapid SARS-CoV-2 antibody detection.
The clinical course of COVID-19 is notable for its extreme variability. Understanding the factors influencing this spectrum of outcomes - including the variable human immune - is an area of focus.
The authors used a technology known as VirScan - a tool members of the same group developed previously - to explore the antibody response to SARS-CoV-2 and other human coronaviruses in more than 200 COVID-19 patients and nearly 200 pre-COVID-19 era controls.
Blood serum from COVID-19 patients exhibited much more SARS-CoV-2 reactivity compared to pre-COVID-19 era controls, though some cross-reactivity toward SARS-CoV-2 peptides was observed in the pre-COVID-19 era samples, say the authors; this was expected, they note, since nearly everyone has been exposed to human coronaviruses.
However, only COVID-19 patients' antibodies primarily recognized peptides derived from the spike (S) and nucleoprotein (N) of the virus. Those members of the SARS-CoV-2-infected group who had been hospitalized for their infection exhibited stronger and broader antibody responses to S and N peptides, the authors report. In the same (hospitalized) group, antibody responses to nearly all viruses, except SARS-CoV-2, were weaker; as well, males exhibited greater SARS-CoV-2 antibody responses than females. This latter finding, consistent with reported differences in disease outcomes for males and females, may indicate that males in this group are less able to control the virus soon after infection.
A machine learning model trained on the VirScan results accurately classified patients infected with SARS-CoV-2. Drawing insights from this model about peptides highly predictive of SARS-CoV-2 guided the design of simple, rapid diagnostic for COVID-19, which predicted SARS-CoV-2 exposure with 90% sensitivity and 95% specificity. "Altogether these data help explain why many serological assays for SARS-CoV-2 produce false positives and should be taken as a cautionary note for those trying to develop such assays," the authors write.
https://science.sciencemag.org/content/early/2020/09/28/science.abd4250
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fviral-epitope-profiling&filter=22
Signatures of cross-reactivity and severity in COVID-19
- 820 views
- Added
Edited
Latest News
Men with gene mutations are…
By newseditor
Posted 17 May
B cell oxidative phosphoryl…
By newseditor
Posted 17 May
Human brain gene therapy us…
By newseditor
Posted 16 May
Small-molecular mimic of a…
By newseditor
Posted 16 May
Centromere structure and ch…
By newseditor
Posted 16 May
Other Top Stories
Random networks of neurons can predict the timing stimulus
Read more
Brain imaging-based biomarker of depression identified!
Read more
Genetic variant linked with faster progression of multiple sclerosis
Read more
How cells rewrite their fate
Read more
Neuronal signal needed for blood-brain barrier development!
Read more
Protocols
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Methods for making and obse…
By newseditor
Posted 15 May
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Publications
Obesity-induced blood-brain…
By newseditor
Posted 18 May
CRISPR/Cas9 model of prosta…
By newseditor
Posted 17 May
Modulation of host immunity…
By newseditor
Posted 17 May
Variability in cell divisio…
By newseditor
Posted 17 May
Biallelic BORCS8 variants c…
By newseditor
Posted 17 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar